These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2075125

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hypervolemic treatment of the chronic obliterative arteriopathies of extremities.
    Brassai Z, Koválszki P, Pop GH, Kiss K, Olosz E.
    Med Interne; 1986; 24(1):37-41. PubMed ID: 2422732
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Intra-arterial infusion therapy of patients with the ischemic syndrome in thrombo-obliterating diseases of the lower extremities in ambulatory conditions].
    Savel'ev IuS.
    Vestn Khir Im I I Grek; 1990 Sep; 145(9):131-4. PubMed ID: 1962927
    [No Abstract] [Full Text] [Related]

  • 7. Clinical experience with prostaglandin E1 in the treatment of arteriosclerosis obliterans. A preliminary report.
    Ambrus JL, Taheri P, Killion D, Donaldson G.
    J Med; 1983 Sep; 14(1):1-15. PubMed ID: 6577118
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of patients with occlusive arterial diseases of the legs with prostaglandin E1].
    Dibirov MD.
    Vestn Khir Im I I Grek; 1988 Jun; 140(6):137-8. PubMed ID: 3222855
    [No Abstract] [Full Text] [Related]

  • 9. [Diagnosis and treatment of chronic critical ischemia of the lower extremity tissues].
    Vlaĭkov HH.
    Klin Khir; 2008 Sep; (9):27-30. PubMed ID: 19275032
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Use of vasoprostan in the treatment of obliterating atherosclerosis of the lower limbs].
    Sukharev II, Guch AA.
    Klin Khir (1962); 1994 Sep; (7):22-4. PubMed ID: 7823491
    [Abstract] [Full Text] [Related]

  • 16. Conservative treatment of inoperable arterial occlusions of the lower extremities with intra-arterial prostaglandin E1.
    Gruss JD, Bartels D, Ohta T, Machado JL, Schlechtweg B.
    Br J Surg; 1982 Jun; 69 Suppl():S11-3. PubMed ID: 7044465
    [Abstract] [Full Text] [Related]

  • 17. Muscle contraction and excitation in chronic peripheral vascular disease.
    Miglietta O.
    Arch Phys Med Rehabil; 1969 Feb; 50(2):81-5 passim. PubMed ID: 5766266
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The clinical aspects of using Vazaprostan in patients with atherosclerotic involvement of the vessels of the extremities].
    Krotovskiĭ GS, Zabel'skaia TF, Mamedov DM.
    Ter Arkh; 1991 Feb; 63(8):64-8. PubMed ID: 1792622
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.